[Federal Register Volume 85, Number 84 (Thursday, April 30, 2020)]
[Notices]
[Pages 23982-23983]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09244]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Integrating Biospecimen Science Approaches into Clinical
Assay Development.
Date: June 11, 2020.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, Medical Center
Drive, Room 7W242, Rockville, MD 20850 (Telephone Conference Call).
Contact Person: Zhiqiang Zou, M.D., Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W242, Bethesda, MD 20892, 240-276-6372, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-4: NCI Clinical and Translational R21 and Omnibus R03
Review.
[[Page 23983]]
Date: June 12, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W112, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Jennifer C. Schiltz, Ph.D., Special Review
Branch, Division of Extramural Activities, National Cancer
Institute, 9609 Medical Center Drive, Room 7W112, Rockville, MD
20850, 240-276-5864, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Small Cell Lung Cancer Consortium.
Date: June 16, 2020.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove Medical Center
Drive, Room 7W116, Rockville, MD 20850 (Telephone Conference Call).
Contact Person: Klaus B. Piontek, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, 9609 Medical Center Drive, Room 7W116, National Cancer
Institute, Rockville, MD 20892-9750, 240-276-5413,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Utilizing the Prostate, Lung, Colorectal, and Ovarian Cancer
(PLCO) Biospecimens Resources (U01).
Date: June 23, 2020.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W122, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Anita T. Tandle, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W122, Bethesda, MD 20892, 240-276-5085,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Radiobiology of High Linear Energy Transfer Exposure in
Cancer Treatment.
Date: June 25, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W108, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Clifford W. Schweinfest, Ph.D., Scientific
Review Officer, Special Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W108, Bethesda, MD 20892-8329, 240-276-6343,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-6: NCI Clinical and Translational R21 and Omnibus R03
Review.
Date: June 26, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W236, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Robert Stephen Coyne, Ph.D., Scientific Review
Officer, National Cancer Institute, NIH Division of Extramural
Activities, Special Review Branch, 9609 Medical Center Drive, Room
7W236, Rockville, MD 20850, 240-276-5120, [email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Pathway to Independence Award for Outstanding Early Stage
Postdoctoral Researchers.
Date: July 1, 2020.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W238, Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Byeong-Chel Lee, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W238, Rockville, MD 20850, 240-276-7755, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: April 27, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-09244 Filed 4-29-20; 8:45 am]
BILLING CODE 4140-01-P